1) vitreous membranes
玻璃体增殖机化
1.
Methods 96 eyes in 8 0 cases with RD and vitreous membranes were measured by using 2-dimensional ult r asound and CDFI for image and blood flow iamging.
目的 探讨彩色多普勒血流显像 (CDFI)技术对视网膜脱离与玻璃体增殖机化的诊断价值。
2) proliferative vitreoretinopathy/chemically induced
增殖性玻璃体视网膜病变/化学诱导
4) proliferative vitreoretinopathy
增殖性玻璃体视网膜病变
1.
Electroretinogram of 5-fluorouracil and LMWH prevention of proliferative vitreoretinopathy;
氟尿嘧啶联合低分子肝素预防增殖性玻璃体视网膜病变的视网膜电图
2.
Preparing retinoic acid nanosuspensions and preventing experimental proliferative vitreoretinopathy;
维甲酸纳米颗粒混悬剂的制备及对实验性增殖性玻璃体视网膜病变的预防作用
3.
Effects of intravitreal administration of triamcinolone acetonide on postoperative proliferative vitreoretinopathy;
曲安奈德预防术后增殖性玻璃体视网膜病变临床观察
5) traumatic proliferative vitreoretinopathy
外伤性增殖性玻璃体视网膜病变
1.
AIM: To investigate whether telomerase catalytic sub-unit (TERT) takes part in the regulation of cell proliferation in epiretinal membranes in traumatic proliferative vitreoretinopathy (PVR) and its dynamic change.
目的:探讨端粒酶催化亚单位(TERT)是否参与了实验性外伤性增殖性玻璃体视网膜病变(PVR)视网膜前膜的细胞增殖调控及其随病程的动态变化。
2.
[Objective] To analyze the pathology of traumatic proliferative vitreoretinopathy(TPVR)by using proliferating cell nuclear antigen(PCNA)as a mark to observe the proliferative course during the development of experimental traumatic proliferative vitreoretinopathy(TPVR)and study the risk factors,the initial points and the roles of different cells in the formation of TPVR.
[目的]观察实验性外伤性增殖性玻璃体视网膜病变(traumatic proliferative vitreoretinopathy TPVR)的病理过程,以增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)为细胞增殖指标,探讨TPVR的危险因素、增殖起点及各种增殖细胞的作用。
补充资料：机化
机化
①指新生肉芽组织取代坏死组织的过程。②指纤维结缔组织取代凝血块的过程。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条